Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melody Smith

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Blood|March 9, 2023
Harnessing ADR T cells to enhance allo-HCTMelody Smith
Cancer Cell|March 11, 2025
Epigenetic enhancement of adoptive T cell immunotherapyZhenyu Dai, Melody Smith
Frontiers in Immunology|June 6, 2022
Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCLNikeshan Jeyakumar, Melody Smith
Blood|August 14, 2024
The intestinal microbiota and cellular therapy: implications for impact and mechanismsJiayi Xie, Melody Smith
NEJM Evidence|May 28, 2024
An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority PatientsLaQuisa C Hill, Melody Smith
Blood|October 19, 2023
Microbes matter in pediatric allo-HSCTMelody Smith, Kate A Markey
Qualitative Health Research|August 13, 2021
Recommendations for Virtual Qualitative Health Research During a PandemicTessa Pocock, Melody Smith, Janine Wiles
Journal of Physical Activity & Health|February 6, 2025
Who Are We Excluding From Physical Activity Research? Examining the Potential for Exclusion Bias in Pedometer Data ProcessingMelody Smith, Alana Cavadino, Anantha Narayanan
Blood Advances|March 3, 2025
Antibiotic Use: Impact on the Microbiome and Cellular Therapy OutcomesAlicia Darwin, Jiayi Xie, Melody Smith
Blood|January 24, 2018
Posttransplant chimeric antigen receptor therapyMelody Smith, Johannes Zakrzewski, Scott James, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Blood|March 9, 2023
Harnessing ADR T cells to enhance allo-HCTMelody Smith
Cancer Cell|March 11, 2025
Epigenetic enhancement of adoptive T cell immunotherapyZhenyu Dai, Melody Smith
Frontiers in Immunology|June 6, 2022
Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCLNikeshan Jeyakumar, Melody Smith
Blood|August 14, 2024
The intestinal microbiota and cellular therapy: implications for impact and mechanismsJiayi Xie, Melody Smith
NEJM Evidence|May 28, 2024
An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority PatientsLaQuisa C Hill, Melody Smith
Blood|October 19, 2023
Microbes matter in pediatric allo-HSCTMelody Smith, Kate A Markey
Qualitative Health Research|August 13, 2021
Recommendations for Virtual Qualitative Health Research During a PandemicTessa Pocock, Melody Smith, Janine Wiles
Journal of Physical Activity & Health|February 6, 2025
Who Are We Excluding From Physical Activity Research? Examining the Potential for Exclusion Bias in Pedometer Data ProcessingMelody Smith, Alana Cavadino, Anantha Narayanan
Blood Advances|March 3, 2025
Antibiotic Use: Impact on the Microbiome and Cellular Therapy OutcomesAlicia Darwin, Jiayi Xie, Melody Smith
Blood|January 24, 2018
Posttransplant chimeric antigen receptor therapyMelody Smith, Johannes Zakrzewski, Scott James, et al.
Pageof 12